These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8433095)

  • 21. 21-Aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia.
    Young W; Wojak JC; DeCrescito V
    Stroke; 1988 Aug; 19(8):1013-9. PubMed ID: 3400099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke.
    Wilson JT; Bednar MM; McAuliffe TL; Raymond S; Gross CE
    Neurosurgery; 1992 Nov; 31(5):929-33; discussion 933-4. PubMed ID: 1436419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs.
    Natale JE; Schott RJ; Hall ED; Braughler JM; D'Alecy LG
    Stroke; 1988 Nov; 19(11):1371-8. PubMed ID: 3188122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs.
    Matsui T; Asano T
    Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium.
    Holzgrefe HH; Buchanan LV; Gibson JK
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):239-48. PubMed ID: 1689419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats.
    Yue G; Sun FF; Dunn C; Yin K; Wong PY
    J Pharmacol Exp Ther; 1996 Jan; 276(1):265-70. PubMed ID: 8558441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U74006F) on hepatic endothelium in experimental hemorrhagic shock.
    Eversole RR; Smith SL; Beuving LJ; Hall ED
    Circ Shock; 1993 Jun; 40(2):125-31. PubMed ID: 8508516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a 21-aminosteroid, U74006F, on lipid peroxidation and glomerulotubular function following experimental renal ischemia.
    Shackleton CR; Ettinger SL; Scudamore CH; Toleikis PF; Keown PA
    J Surg Res; 1994 Oct; 57(4):433-7. PubMed ID: 7934019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the 21-aminosteroid U74006F on experimental head injury in mice.
    Hall ED; Yonkers PA; McCall JM; Braughler JM
    J Neurosurg; 1988 Mar; 68(3):456-61. PubMed ID: 3343616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.
    Hall ED; Pazara KE; Braughler JM
    Stroke; 1991 Mar; 22(3):361-6. PubMed ID: 2003306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic cerebral intracellular alkalosis following forebrain ischemic insult in rats.
    Chopp M; Vande Linde AM; Chen H; Knight R; Helpern JA; Welch KM
    Stroke; 1990 Mar; 21(3):463-6. PubMed ID: 2309271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F.
    Hall ED; Yonkers PA
    Stroke; 1988 Mar; 19(3):340-4. PubMed ID: 3354019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.
    Aoki N; Lefer AM
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):205-10. PubMed ID: 1689414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tirilazad pretreatment improves early cerebral metabolic and blood flow recovery from hyperglycemic ischemia.
    Maruki Y; Koehler RC; Kirsch JR; Blizzard KK; Traystman RJ
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):88-96. PubMed ID: 7798342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy with U74006F (tirilazad mesylate), MK-801, insulin and diazepam in transient forebrain ischaemia.
    Auer RN
    Neurol Res; 1995 Apr; 17(2):132-6. PubMed ID: 7609850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury.
    Sato PH; Hall ED
    J Neurochem; 1992 Jun; 58(6):2263-8. PubMed ID: 1573405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 21-aminosteroid U74006F reduces systemic lipid peroxidation, improves neurologic function, and reduces mortality after cardiopulmonary arrest in dogs.
    Natale JE; Schott RJ; Hall ED; Braughler JM; D'Alecy LG
    Prog Clin Biol Res; 1989; 308():891-6. PubMed ID: 2780736
    [No Abstract]   [Full Text] [Related]  

  • 38. Blocking weight-induced spinal cord injury in rats: therapeutic effect of the 21-aminosteroid U74006F.
    Holtz A; Gerdin B
    J Neurotrauma; 1991; 8(4):239-45. PubMed ID: 1803032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of U74006F on neurologic function and brain edema after fluid percussion injury in rats.
    Sanada T; Nakamura T; Nishimura MC; Isayama K; Pitts LH
    J Neurotrauma; 1993; 10(1):65-71. PubMed ID: 8320733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of postischemic intracellular alkalosis reflects the duration of ischemia.
    Chopp M; Chen H; Vande Linde AM; Brown E; Welch KM
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):860-5. PubMed ID: 2211879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.